• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 577.0
  • ISIN : INE351A01035
696.90 -3 (-0.39%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    692.15

  • Today’s High

    706.40

  • Open

    700.00

  • Perv Close

    699.65

  • 52W Low

    489.00

  • 52W High

    937.95

Key Indicators

  • P/E(TTM)

    39.86

  • Mar.Cap (₹Cr.)

    4,906.58

  • Div & Yield %

    0.00

  • Book Value(₹)

    335.24

  • Debt-Equity Ratio

    -0.39

  • AGM Date

    28-Mar-2025

  • EPS

    17.38

  • P/E Ratio

    39.86

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    4,906.58

  • RONW (%)

    -1.17

  • ROCE (%)

    0.39

Score Board

  • Equity (₹ in Cr.)

    14.08

  • BV (₹)

    335.20

  • Sales( ₹ in Cr.)

    1,442.17

  • NP (in Cr.)

    -36.24

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    9.80

  • EPS (₹)

    -5.10

  • Traded Value (₹ in Lakhs)

    4,877.71

  • 52 Week High

    937.95

  • 52 Week Low

    489.00

  • Price BSE

    693.0

  • Price NSE

    697.00

  • Market Capital( in Cr.)

    4,877.71

  • P/C Ratio

    70.50

  • P/E Ratio

    -134.60

  • Price Vs.BV

    -5.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,442.17 1,072.43 942.93 1,123.97 904.44 967.74
Excise Duty 1,392.62 1,030.51 919.18 1,078.52 850.53 910.41
Net Sales 1,442.17 1,072.43 942.93 1,123.97 904.44 967.74
Other Income 30.39 41.85 42.07 47.37 99.17 101.54
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,472.55 1,114.28 984.99 1,171.34 1,003.61 1,069.28
EXPENDITURE :
Raw Materials 1,392.62 1,030.51 919.18 1,078.52 850.53 910.41
Power & Fuel Cost 1,392.62 1,030.51 919.18 1,078.52 850.53 910.41
Employee Cost 283.14 270.86 250.79 234.04 205.16 176.76
Other Manufacturing Expenses 0.00 3.70 8.95 3.28 3.48 19.29
Selling & Administrative Expenses 236.37 194.89 192.65 225.80 263.43 281.65
Miscellaneous Expenses 0.00 3.70 8.95 3.28 3.48 19.29
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,507.13 1,280.71 1,071.74 1,105.70 1,067.42 1,090.86
Operating Profit 180.26 172.02 150.61 132.44 140.23 137.99
Interest 10.42 9.38 2.07 1.30 1.28 0.62
Gross Profit -92.18 -279.09 -86.75 65.65 -63.81 -21.58
Depreciation 105.46 105.98 83.19 75.89 71.09 61.71
Profit Before Tax -92.18 -279.09 -86.75 65.65 -63.81 -21.58
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 20.61 -31.56 10.94 -7.50 -27.38
Reported Net Profit -92.18 -299.70 -55.43 54.08 -56.32 7.04
Extraordinary Items -92.18 -279.09 -86.75 65.65 -63.81 -21.58
Adjusted Net Profit -92.18 -299.70 -55.43 54.08 -56.32 7.04
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 2.47
Statutory Appropriations 0.00 28.16 28.16 28.16 28.16 28.15
P & L Balance carried down -92.18 -299.70 -55.43 54.08 -56.32 7.04
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 200.00 200.00 200.00 200.00 200.00
Dividend Per Share(Rs) 0.00 4.00 4.00 4.00 4.00 4.00
Earnings Per Share-Unit Curr -13.09 -42.57 -7.87 7.68 -8.00 1.25
Book Value 0.00 28.16 28.16 28.16 28.16 28.15
Book Value(Adj)-Unit Curr 0.00 28.16 28.16 28.16 28.16 28.15

Shareholding Pattern

  • Promoter Group

    70.22%

  • Public Share Holding

    29.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,221,224 17.36 12,221,224 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 37,219,362 52.86 37,219,362 4
Others 0 0.00 0 0
Sub Total 49,440,586 70.22 49,440,586 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,954 0.03 22,454 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 743,018 1.06 742,518 40
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 500 0.00 500 1
Insurance Companies 153,628 0.22 153,628 2
Mutual Funds / UTI 7,179,178 10.20 7,179,178 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 833,321 1.18 833,321 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,932,599 12.69 8,931,599 56
2] Non Institution
Bodies Corporate 237,251 0.34 237,171 148
Clearing Members 36 0.00 36 3
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 412,604 0.59 410,604 442
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 349,264 0.50 349,264 618
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,038,723 1.48 370,598 4
Individuals holding nominal share capital up to Rs. 1 lakh 9,149,803 13.00 8,310,209 20,180
Market Maker 2 0.00 2 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 744,892 1.06 744,892 1
Sub Total 12,032,565 17.09 10,522,766 21,408
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 70,405,750 100.00 68,894,951 21,472

Company Background

Unichem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Unichem Laboratories Ltd
  • BSE Code : 577.0
  • ISIN : INE351A01035

  • Incorporation Year

    1962

  • Registered Office

    Unichem Bhavan Prabhat Estate
    Off S V Road Jogeshwari (West), Mumbai,
    Maharashtra-400102

  • Telephone

    91-22-66888333

  • FAX

    91-22-26784391

  • Chairman

    Prakash A Mody

  • Managing Director

    Pabitra Bhattacharya

  • Company Secretary

    Pradeep Bhandari

  • Auditor

    N A Shah Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Unichem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unichem Labs. 692.80 1,472.55 1,442.17 -1,506.09 -1.05
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92